News - Management


Current filters:


Popular Filters

176 to 200 of 229 results

News briefs from Merck KGaA and Sanofi


German drug major Merck KGaA )MRK: DE) revealed this morning that its Phase III EXPAND trial, which assessed…

cilengitideErbituxManagementMerck KGaAMergers & AcquisitionsPharmaceuticalResearchSanofi

Roche to close Nutley, USA, site with 1,000 job losses


Swiss drug major Roche (ROG: SIX) yesterday announced a consolidation and streamlining of research activities,…


Icahn tries again to nominate Forest Labs board members


In a second proxy fight against US drugmaker Forest Laboratories (NYSE: FRX), billionaire investor Carl…

Forest LaboratoriesManagementPharmaceutical

Lundbeck restructures, with 600 job cuts anticipated


Denmark-based CNS specialist Lundbeck (LUN: CO) last week announced plans to restructure its commercial…


Senior exec appointments at Pfizer


Global pharma behemoth Pfizer (NYSE: PFE) has named Olivier Brandicourt as president and general manager…


Newron executes safinamide deal with Zambon; new Ph III data; management changes


In what was a busy news day for Italian drug developer Newron Pharmaceuticals SpA (SIX: NWRN), the company…

FinancialLicensingManagementNeurologicalNewron PharmaPharmaceuticalResearchsafinamideZambon

Exec appointments at Novo Nordisk and Teva


Danish insulin giant Novo Nordisk (NOV: N) says that former Pfizer executive Robert Clark will be joining…

GenericsManagementNovo NordiskPharmaceuticalTeva Pharmaceutical Industries

New business model to relaunch the BioPharma industry, from ADL


Traditionally, clinical diagnoses and treatments have focused on diseases and cures. For every ailment,…

BiotechnologyManagementMarkets & MarketingPharmaceutical

AstraZeneca CEO to go early, as 1st-qtr sales and profits plunge; makes deal with TMC for cardiovasculars


Anglo-Swedish drug major AstraZeneca (LSE: AZN) stunned the markets this morning, announcing that its…

AstraZenecaCardio-vascularFinancialLicensingManagementPharmaceuticalThe Medicines Company

Merck KGaA to rationalize operations in Switzerland


German drug major Merck KGaA (MRK: DE) has announced efficiency measures it plans to take related to…

BiotechnologyManagementMerck KGaAMerck SeronoPharmaceuticalResearch

Senior exec changes actual or sought at Johnson & Johnson, AstraZeneca and Optimer


US health care giant Johnson & Johnson (NYSE: JNJ) said on Monday that Sherilyn (Sheri) McCoy, vice chairman…

AstraZenecaJohnson & JohnsonManagementOptimer PharmaceuticalsPharmaceutical

Most admired pharma companies in Japan, by IAL


Since 1999 International Alliances Limited (IAL), headed by P Reed Maurer, has conducted an annual survey…

Asia-PacificManagementMarkets & MarketingPharmaceutical

Senior appointments as Sanofi and Onyx


French drug major Sanofi (Euronext: SAN) has named former Bayer executive Jean-Luc Lowinski as senior…

ManagementOnyx PharmaceuticalsPharmaceuticalSanofi

EMA increases public information on conflicts of interest of experts and management


The European Medicines Agency this week updated its list of European experts to display each expert's…


Merck KGaA sets out efficiency program, with cost and job cuts likely


Adding to the list of pharma companies announcing significant structural changes and job cuts, on Friday…

FinancialManagementMerck KGaAPharmaceutical

Alex Gorsky named as CEO of Johnson & Johnson


Troubled US health care giant Johnson & Johnson (NYSE: JNJ) last night announced that its board of directors…

Johnson & JohnsonManagementPharmaceutical

LEO Pharma sales reps file suit on overtime in USA


Attorneys from Sanford Wittels & Heisler have filed a class action complaint in the US District Court…

LegalLEO PharmaManagementNorth AmericaPharmaceutical

Two hurdles to jump for SkyePharma, as it changes CEO


On the same day that UK-based SkyePharma (LSE: SKP) announced that Axel Mueller has resigned as chief…

3MEuropeFinancialFlutiformManagementPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

Novartis resolves US class action on wage and hour claims


The US subsidiary of Swiss drug major Novartis (NOVN: VX) says it has reached an agreement to resolve…

LegalManagementNorth AmericaNovartisPharmaceutical

Alnylam looks to save $20 million via restructuring


USA-based RNAi therapeutics specialist Alnylam Pharmaceuticals (Nasdaq: ALNY) said last week that it…

Alnylam PharmaceuticalsBiotechnologyFinancialManagement

Takeda cuts 2,800 jobs as it assimilates Nycomed


Japan’s largest drugmaker Takeda Pharmaceutical (TSE: 4502) yesterday announced strategic measures…

FinancialManagementNycomedPharmaceuticalResearchTakeda Pharmaceuticals

Novartis cuts jobs, takes $1.22 billion charges


In anticipation of the blockbuster antihypertensive Diovan’s (valsartan) patent expiration and an…


Knighthood for GlaxoSmithKline’s Andrew Witty; Teva succession plan


Andrew Witty, chief executive of UK drug giant GlaxoSmithKline (LSE: GSK) has been awarded a Knighthood…

GenericsGlaxoSmithKlineManagementPharmaceuticalTeva Pharmaceutical Industries

Ex-EMA head set up consultancy while still in office


New evidence shows that the former head of the European Medicines Agency, Thomas Lonngren, set up his…


176 to 200 of 229 results

Back to top